Sneha Trivedi*

Assistant Professor, Shree Ramkrishna Institute of Computer Education and Applied Science, Sarvajanik University, India

*Corresponding Author: Sneha Trivedi, Assistant Professor, Shree Ramkrishna Institute of Computer Education and Applied Science, Sarvajanik University, India.

Received: September 15, 2021; Published: October 01, 2021

Citation: Sneha Trivedi. “Recombinant Vaccines - Rise of a New Era of Vaccination". Acta Scientific Microbiology 4.11 (2021): 01.

  It has been more than a century since Louis Pasteur presented Rabies Vaccine to humanity, we have come a long way in terms of vaccinations since then. The traditional and established approach for vaccine designing lies in the principle of isolation, attenuation or killing and injection. And most of the vaccines produced followed those basic steps given by Louis Pasteur. However, now as the world is changing with the pace of technological advancements, the modern approach for vaccine construction lies in isolation, attenuation or inactivation and ‘Recombination’. In 1986, the first recombinant vaccine Recombivax HB for hepatitis B was approved for human use in several countries. It was the final output of the research initiated in 1979 by William Rutter, Pablo Valenzuela and their colleagues on the cloning of HBV Ag. Since then, recombinant vaccines and it’s designing are increasing for immunization against number of diseases including tuberculosis.

Copyright: © 2021 Sneha Trivedi. “Recombinant Vaccines - Rise of a New Era of Vaccination". This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.